TOPIRAMATE ER 150 MG SPRINK CAP

What it is

TOPIRAMATE ER 150 MG SPRINK CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as topiramate.

FDA gives its dosage form as capsule, extended release and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Upsher-Smith Laboratories, LLC, Glenmark Pharmaceuticals Inc., USA and Vitruvias Therapeutics, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 5 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $220.71 for 30 capsules (30 × $7.35688 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 capsules · NADAC explanation codes

All 5 NDCs

• 00832-1075-30 · Upsher-Smith Laboratories, LLC · $7.35688 per EA · eff. 2026-09-23 filed
• 68462-0370-30 · Glenmark Pharmaceuticals Inc., USA · $7.35688 per EA · eff. 2026-09-23 filed
• 69680-0180-30 · Vitruvias Therapeutics, Inc. · $7.35688 per EA · eff. 2026-09-23 filed
• 70710-1042-03 · Zydus Pharmaceuticals USA Inc. · $7.35688 per EA · eff. 2026-09-23 filed
• 72603-0123-01 · NorthStar RxLLC · $7.35688 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

26 other products in the NADAC file share the FDA nonproprietary name topiramate with TOPIRAMATE ER 150 MG SPRINK CAP. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $395.84 for 30 capsules, at an average of $13.19463 per EA in 2024 (2024-01-01 to 2024-12-31) for “Topiramate ER” and “Topiramate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 35,445 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.